JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
CELG-RI Financials - Bristol Myers Squibb Income & Cash Flow | Ledgeburg
CELG-RI - Bristol Myers Squibb Co.
USD | NYSE | Healthcare
Summary
Summary CELG-RI Stock
Financials
Financials CELG-RI Stock
Loading...
Loading...
Income Statement
Income Statement CELG-RI Stock
Balance Sheet
Balance Sheet CELG-RI Stock
Cash Flow Statement
Cash Flow Statement CELG-RI Stock
Loading...
Loading...
Home
Stocks
Bristol Myers Squibb Co. (CELG-RI)
Financials
Financials of CELG-RI
Loading...
Loading...
Loading...
Loading...
Revenue
$48.194B
Operating Income
N/A
Net Income
$7.055B
Share Count (Basic)
2.034B
Operating Cash Flow
$14.156B
Free Cash Flow
$12.845B
Cash And Short-Term Equivalents
$10.209B
Total Debt
$44.827B
Annual
Quarterly
Revenue $USD
0
10B
20B
30B
40B
50B
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
5B
10B
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-10B
-5B
0
5B
10B
Annual
Quarterly
Margins
Gross
Operating
Net
-20%
0%
20%
40%
60%
80%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
500M
1B
1.5B
2B
2.5B
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26